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The possible role of enteroviral persistence in the etiology of the chronic fatigue syndrome 
(CFS) was investigated by serological testing, VFM antigen testing, and polymerase chain reac­
tion (PCR) analysis of stool specimens as well as by viral cultures of stool— both direct and after 
acid treatment. No differences between 76 patients with disabling unexplained fatigue and 76 
matched controls were found by serological or antigen testing. Furthermore, no enteroviruses 
were isolated from any stool culture. Enterovirus was detected by PCR in one stool specimen 
from a patient with CFS but was not detectable in a second sample obtained from the same 
patient 3 months later. All stool specimens from controls were PCR-ncgative. These results 
argue against the hypothesis that enteroviruses persist in patients with CFS and that their persis­
tence plays a role in the pathogenesis of this syndrome.
The chronic fatigue syndrom e (CFS) is characterized by 
excessive fatigue o f  at least 6 m onths ' duration. Usually this 
fatigue is accom panied by a variety o f  nonspecific symptoms, 
such as myalgia, im pairm ent o f  memory, and difficulties in 
concentration. The disease leads to a dim inution o f  physical 
and mental functioning.
The etiology o f  CFS is not known. However, many pa­
tients with CFS believe that an infectious disease is the 
inciting event. Viruses that have been associated with CFS 
include Epstein-Barr virus, hum an herpesvirus 6 , cytomega­
lovirus, retroviruses, and enteroviruses. O f  the enteroviruses, 
the coxsackie B viruses have been considered particularly 
likely to be involved in CFS because o f  their myotropic and 
neurotropic character.
Support for an etiologic role o f  enteroviruses in CFS is 
derived from studies in the United Kingdom [ 1-5]. Several 
investigators have found enterovirus in stool (by culture) [ 1 ], 
in blood (by the VP-1 test) | I ], and in muscle (by slot-blot 
hybridization and the polymerase chain reaction [P C R ]) [2 -
4]. In addition, one group reported high levels o f  neutraliz­
ing antibodies to coxsackie B viruses [5J. On the basis of 
these results, it was suggested that the persistence ofenterovi- 
ruses plays a role in CFS [ 1, 3-5]. O ther studies, however, 
failed to confirm such a role [6- 8]. In the latter studies, both 
antibodies to enteroviruses and VP-1 antigen were found 
with equal frequency in patients with CFS and in controls.
O ur aim in this study was to investigate the persistence of
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enteroviruses in a group o f  patients with CFS and in a well- 
matched control group. To this end, we performed enterovi­
rus-specific serological testing and VP-1 antigen testing on 
serum samples, and we subjected stool samples to PCR and 
viral culture (both direct and after acid treatm ent for the 
dissociation o f  putative im m une complexes). This study was 
part o f  a broader multidisciplinary investigation evaluating 
clinical, psychological, and laboratory data from patients 
with CFS.
Materials and Methods
Patients. Seventy-six patients and 76 healthy controls 
were examined. Patients were randomly chosen from a data 
base o f  298 patients with CFS. (This group, which was self- 
referred. has been described in detail by Vercoulen et al. [9].) 
All patients reported severe, unexplained, debilitating fa­
tigue o f  at least I year's duration. T he enrolled patients came 
to our outpatient clinic twice within a 3-month interval. On 
the second visit, each patient was accom panied by a neigh­
bor o f  the same gender and within 2 years o f  the same age; 
this control was selected by the patient. Patients and controls 
visited our clinic between Decem ber 1991 and April 1992 
a period covering m onths during which the incidence o f  in­
fections due to enteroviruses is usually low in the Nether-■/
lands. Samples o f  blood and stool were obtained from 
patients and controls. All patients underw ent a physical ex­
am ination and an extensive laboratory work-up and com ­
pleted a questionnaire that solicited information on age, sex. 
and duration and nature o f  symptoms.
Antibodv-capture ELISA. A broadly reactive antibody- 
capture ELISA was used for the detection o f  IgG, IgM, and 
IgA antibodies to enteroviruses [10]. A strongly positive 
serum sample, a “ cu to ff ' sample, and a negative control sam ­
ple were included in each test. The cutoff value was based on 
the assumption that at most 5rc o f  serum samples from 200
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healthy blood donors would he reactive. Thus levels were 
scored as positive (greater than the cutoff value) only when 
they exceeded those in a healthy population. Serum samples 
from patients and controls were tested simultaneously in 
order to minimize the day-to-day variability o f  the assay.
Complément-fixation test. The C F test was performed ac­
cording to the microtiter technique described by Casey [ I I ] .  
The enteroviral antigen used in this test (Behringwerke AG. 
Marburg, G erm any) actually consisted o f  a mixture o f  an ti­
gens, including those o f  coxsackieviruses B1 through B5; 
coxsackievirus A9; and echoviruses 4, 6 , 9, 14, 24. and 30. 
The CF titer was expressed as the reciprocal o f  the highest 
dilution showing 50% hemolysis. Serum samples from pa­
tients and controls were tested simultaneously.
VP-1 test. The VP-1 antigen test was performed at the 
laboratory o f  Dr. J. F. Mowbray (D epartm ent o f  Im m unopa- 
thology, St. M ary’s Hospital Medical School, London). The 
enterovirus group-reactive m onoclonal antibody 5-D8/1 was 
used [12]. Serum samples from patients and controls were 
random ly num bered for blind test in«.J
Isolation o f  virus from stool sped  meus. A 100-m L suspen­
sion o f  feces in PBS (20%, w t/vol) was prepared from every 
stool specimen. Chloroform ( 10%, vol/vol) was added, and 
the mixture was shaken vigorously for 20 minutes. Superna- 
tants were clarified by centrifugation at low speed ( 2.000 g). 
A 5-mL volume o f  supernatant was used to inoculate dupli­
cate tubes containing hum an fetal lung fibroblasts ( no. 2002 ; 
Flow Laboratories, Rockville, M D) and tertiary kidney cells 
from cynom olgus monkeys [ 1 3] (0.1 mL o f  supernatant and
0.25 mL o f  culture medium per tube). After absorption o f 
the inoculum  for 1 hour at 37°C, the inoculum was decanted 
and replaced by 1 mL o f  the following culture medium; m in­
imal essential medium (M EM ) with 3% fetal bovine serum 
(FBS), 20 m M  HEPES (pH 7.5), 2 m M  glutamine, 50 ^g o f 
gentam icin /m L, 100 fig o f  vancom ycin/m L, and I /ig o f  am ­
photericin B/mL. The tubes were incubated at 37°C  and 
were examined for cytopathic effect (CPE) every 3 days for 2 
weeks. A blind passage was undertaken after 1 week.
The remaining 95-mL volume o f  supernatant was centri­
fuged in two bottles at 150,000 g for 3 hours. The 
supernatants were removed. One pellet was resuspended in 
2.5 mL o f  MEM with 3% FBS and stored at —70°C for acid 
elution. The other pellet was stored directly at —70°C 
for PCR.
Table 1. Enteroviral primer sequences used for nested PCR.
Primer Oligonucleotide sequence Location*
1 5 '-CA A G CA C TTCTG TTTC CC CG G -3 ' 160-180
2 5-T C C T C C G G C C C C T G A A T G C G -3 ' 445 -464
3 5 '-ATTG TCA CCA TAA G CA G CCA-3 ' 580-599
4 5 '-CACCGGATGGCCAATCCA-3 ' 626 -643
5 '-T G T G T C G T A A C G G G C A A C T C T -
Probe G C A G C G G A A -3 ' 509-538
* Positions refer to the coxsackievirus Bl sequence o f  lizuka el al. [ 16].
product had a length o f  484 base pairs (bp). For nested PCR. 
a 10-/uL volume o f  the first PCR reaction product was added 
to a new PCR mixture containing 50 pmol o f  nested primers
2 and 3 and was subjected to an additional 40 cycles o f  am ­
plification. A positive amplification resulted in a product o f 
155 bp. Each test included five controls; a I)NA control 
(cDNA o f coxsackievirus B I ), an RNA control (RN A  o fco x ­
sackievirus Bl). a negative control (diethyl pyrocarbonate 
[DEPC’J-treated distilled water), and RNA isolated from 
stool specimens from two healthy controls. The reactions 
were analyzed by electrophoresis o f  25 fj.L o f  the PCR reac­
tion product on a 1.5% agarose gel stained with ethidium 
bromide and subsequent Southern blot hybridization as de­
scribed previously [ 15], with use o f an end-labeled oligonu­
cleotide probe (table 1).
Isolation o f  virus after acid elution. Acid elution was per­
formed as described by Y ousefet al. [ 1 ] with slight modifica­
tions. In brief, a 1.5-mL volume o f  0 . 1 A/glycine/HCl buffer 
(pH 2.4) was added to 2.5 mL o f  concentrated stool extract,
%
and the pH was readjusted to 2.4 with 0.5 M  HC1. The mix­
ture was incubated at room tem perature for 3 hours and then 
centrifuged over a 30% sucrose cushion at pH 2.4 for 3 hours 
at 150,000 g. T he pellet was resuspended in 2 mL o f  MEM 
with 3% FBS, and the pH was adjusted to 7.0 by the addition 
o f  0.5 M  NaOH. The suspension was then inoculated in du­
plicate onto  tertiary monkey kidney cells and human fetal 
lung fibroblasts (1 mL o f  concentrated stool extract plus 2.5 
mL o f  culture m edium ) seeded in 2 5 -cn r  flasks (no. 690160; 
G reiner G m bH . Frickenhausen, Germ any). After absorption 
for I hour at room temperature, the inoculum was decanted, 
and a 5-mL volume o f  culture medium was added to the 
flasks, which were subsequently incubated at 37°C. The cul-
Nested PCR. Primers were selected from the 5' nontrans- tures were examined for CPE every 3 days for 6 weeks. Blind
lated region, which is highly conserved am ong enteroviruses. 
The primers were 100% homologous to the known en­
teroviral RNA sequences. RNA was extracted from the 
concentrated fecal pellet by the acid guanidinium  thio- 
cyanate-phenol-chloroform  procedure (RNAzol B method; 
C inna/Biotecx Laboratories, Houston. Texas), as described 
by Chomczynski and Sacchi [ 14].
Reverse transcription was performed essentially as de­
scribed by Zoll et al. [ 1 5], with primer 4 as the reverse primer
passages were done after 2 and 4 weeks.
Results
Demographic and clinical information. The mean age o f  
the 76 patients was 40 years (median. 4 1 years; range. 2 0 -6 6  
years); the mean age o f  the 76 controls was 41 years (median. 
42 years; range. 19-67 years). T he male-to-female ratio for 
patients was 1:3. The majority o f  patients reported myalgia, 
and primer 1 as the sense primer (see table 1). The amplified muscular weakness, im pairment o f  memory, and problems
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Figure 1. Scatterplot depicting lack of correlation between en- 
teroviral IgG (ratio) and VP-1 (arbitrary' units [A.U.]). The cutoff 
indicates the upper limit of normal (95% confidence interval).
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Figure 3. Scatterplot depicting lack of correlation between en- 
teroviral IgA (ratio) and VP-1 (arbitrary units [A.U.]). The cutoff 
indicates the upper limit of normal (95% confidence interval).
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with concentration and sleeping. In 90% o f  cases, the criteria 
for CFS delineated by Sharpe et al. [ 17] were fulfilled. The 
average duration o f  symptoms was 1 1 years (m edian. 7 years; 
range, 2 -4 5  years). Sixty-six percent o f  patients reported an 
acute onset o f  the manifestations o f  CFS after an infectious 
illness. Patients were not part o f  a cluster but came from all 
parts o f  the N etherlands (both rural and urban areas).
Serological results. The results o f  the antibody-capture 
ELISA for IgG, IgM. and IgA antibodies to enteroviruses 
were similar for patients and controls (P  >  .05, W ilcoxon 
rank sum test). Likewise, the CF test detected no significant 
difference between patients and controls (P  = .69. x 2 analy­
sis). VP-1 antigen was detected in serum samples from 16 
patients and 17 controls. There was no correlation between 
the presence ofVP-1 antigen and the presence o f  enteroviral 
IgG, IgM. or IgA (figures 1-3); o f  the eight patients whose 
sera were positive for enteroviral IgG. IgM, an d /o r  IgA (table 
2), only one had serum positive for VP-1 antigen. Moreover.
Enterovirus-IgM (ratio)
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Figure 2. Scatterplot depicting lack of correlation between en­
teroviral IgM (ratio) and VP-1 (arbitrary units [A.U.]). The cutoff 
indicates the upper limit of normal (95% confidence interval).
no correlation was found between the outcom e o f  virological 
tests and the duration, nature, or acuteness o f  onset o f  sym p­
toms.
Nested PCR. Nested PCR was used for the analysis o f  
concentrated stool extracts from all 76 patients and all 76 
controls. An amplification product was visualized by gel elec­
trophoresis in one sample from a patient with CFS and in no 
samples from controls; the single positive result was con­
firmed by Southern blot hybridization (figure 4). The patient 
for whom this result was obtained had a negative result in the 
VP-1 antigen test and in serological tests. No enteroviral 
RNA was detected in a second stool specimen obtained from 
this patient 3 m onths later.
Isolation o f  virus from stool specimens. All direct cultures 
o f  stool for enteroviruses gave negative results. Acid elution 
with subsequent culture was undertaken for 23 patients and 
22 controls who had either a high antibody titer (i.e., a titer 
higher than those o f  95% o f  healthy blood donors) or a posi­
tive result in the VP-1 antigen test; for the patient with a 
positive PCR result; and for a random ly selected group o f  22 
o f  the remaining 52 patients. The virological findings for 
these patients are presented in table 2. No virus was isolated.
Discussion
To investigate the possible role o f  enteroviral persistence 
in CFS, we examined serum and stool specimens from 76 
patients with CFS and 76 controls m atched for gender, age, 
and neighborhood. (W e used neighborhood controls to 
correct for the potential effects o f  local epidemics o f  infec­
tion due to enteroviruses.) We found no differences between 
patients and controls in either the prevalence or the titer o f 
enteroviral antibodies, w hether assayed by the CF test or by 
an antibody-capture ELISA broadly reactive with different 
serotypes [ 10]. These results are in agreem ent with those of 
Miller et al. [8], who found no difference between the IgM 
and IgG serum antibody titers o f  patients with CFS and those 
o f  controls. Like Lynch and Seth [6 ] and Halpin and Wessely
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Table 2. Virologica! findings for patients  and  controls  with cultures performed after acid elution.
Test: value given
Value for indicated group
Random patients 
( ” = 22)
Selected* patients 
(// = 24)
Selected* controls 
(/i = 22)
Antibody-capture ELISA: total no. positive 0 8 8
IgG: mean ratio1 (no. >  cutoff) 0.45 (0) 0 .7 0 (5 ) 0.84 (5)
IgM: mean ratio (no. >  cutoff) 0.55 (0) l . l l  (5) 0 .7 0 (4 )
IgA: mean ratio (no. >  cutoff) 0.26 (0) 0 .3 7 (2 ) 0.43 (3)
C F  test: geometric mean (median) titer 39.5 (32) 51.3 (32) 53.6 (32)
VP-I antigen: no. positive 0 16 17
Culture: no. positive 0 0 0
PCR: no. positive 0 1 0
* Selected on the basis o f  a high antibody level a n d / o r a  positive VP-1 lest 
f Extinction o f  test sample divided by extinction o f  cutoff serum sample.
|7 j. we failed to find differences in the prevalence o f  VP-1 
antigen in serum samples from patients and controls. These 
results are in contrast to those obtained by Y ousef et al. [ 1 ]. 
who found VP-1 antigen in the serum o f  44 o f  87 patients 
with postviral fatigue syndrom e (PVFS) but in no serum sam ­
ples from controls.
Enteroviral RNA was detected by PCR in a concentrated 
stool specimen from only one patient with CFS and in no 
such specimens from controls. A stool sample obtained 3 
m onths later from the patient with a positive result was nega-
1 2 3 5 6 7 8 9 10
1631 bp
517 bp 
396 bp 
344 bp 
298 bp 
220 bp
Figure 4. Gel electrophoresis and  Southern blot hybridization o f  
stool specimens subjected to nested PCR in a study o f  patients with 
CFS (lanes 1-4) and  matched controls  (lanes 5 ami 6). Lane 7 
depicts diethyl py rocarbona te - t rea ted  water; lane 8. coxsackievirus 
BI RNA positive control;  lane coxsackievirus BI cD N A  positive 
control;  and  lane 10. size marker pBR322 digested with Hint'I. T he  
larger fragments in lanes 1. 8. and  9 are the results o f  amplification 
with primers I and  4. Arrows indicate the I 55-bp fragment specific 
for amplification o f  enterovirus.
tive for enteroviral RNA. Several research groups have 
shown that the limit o f detection o f  enteroviruses in fecal 
samples by PCR is as low as I pfu [18 ,19]. The sensitivity o f  
the PCR technique described by our group [ I 5] was found to 
be as low as 10 genom e equivalents in a model system but 
was —20 pfu in biological samples. Use o f  nested PCR in­
creased the sensitivity to <1 pfu [20, 21 ]. However, we and 
other investigators [21. 22] have found that fecal samples 
may inhibit the reverse-transcription or the amplification 
step. Negative PCR results for fecal samples should therefore 
be interpreted with caution.
After an acid dissociation step, Y ousef et al. [1] isolated 
enteroviruses from stool specimens from 17 o f  76 patients 
with PVFS; these patients* direct cultures had been negative.
%
However, we isolated no enteroviruses from stool specimens 
from 46 selected patients and 22 selected controls by the 
same technique. Even the patient with a positive PCR result 
had a negative culture after acid elution. Thus, either the 
enterovirus involved in this infection is difficult to isolate in 
cell culture, or PCR is generally more sensitive than culture 
after acid elution. Consistent with a low incidence o f  entero­
viral infections in the winter, ali direct cultures were nega­
tive.
Several investigators have found enteroviral RNA se­
quences in muscle-biopsy specimens from patients w'ith 
PVFS [2-4]. In these studies PVFS was defined as severe 
fatigue starting after an acute episode o f  an apparently viral 
illness and lasting for >1 year [ 1-4] without laboratory evi­
dence o f  an initial infection as required by the definition o f  
Sharpe et al. [ 1 7]. In cooperation with Drs. J. W. Gow and 
P. O. Behan (D epartm ent o f  Neurology, Southern General 
Hospital, Glasgow, United Kingdom), we recently tested 
muscle-biopsy specimens from their patients with PVFS and 
from controls. We detected enteroviral RNA in several sam­
ples. However, the significance o f  such findings is difficult to 
interpret since not only patients but also a num ber o f  con­
trols had positive results ([4] and authors’ unpublished re­
sults). The discrepancy between the latter findings and those
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obtained in the study reported herein may be explained by 
epidemiological differences in viral incidence between the 
U nited Kingdom and the Netherlands. Alternatively, it may 
reflect differences in m ethods o f  patient selection and in case 
definition.
We used the case definition o fC F S  on which consensus 
has been reached in the United Kingdom [ 1 7]; this definition 
is different from that o fP V F S . Still, 66% o f our patients re­
ported an acute onset o f  their sym ptom s after an infectious 
illness and would qualify as having PVFS as defined by You- 
sef et al. [ 1 ] and Gow et al. [4]. The only difference between 
our patients and those in the studies from the United King-
r average duration o f  illness in the former. It 
is unlikely that this difference accounts for the negative re­
sults obtained in our study, however, because there was a 
considerable overlap in the duration o f  illness docum ented 
in the three studies. There was no correlation between the 
duration o f  symptoms or the acuteness o f  onset o f  symptoms 
and the outcom e o f  virological tests in our study. Gow et al. 
found no correlation between the duration o f  PVFS and 
PCR positivity [4]. A similar discrepancy is apparent in the 
incidence o f  enteroviruses in association with the inflam ma­
tory myopathies polymyositis and dermatomyositis: investi­
gators in the United Kingdom have reported the persistence 
o f  enteroviruses in patients with these conditions [3, 23. 24], 
whereas researchers from other geographic areas (including 
our group in the N etherlands) have been unable to detect 
enteroviral RNA in muscle-biopsy specimens from these pa­
tients [25-27].
In summary, we conclude that persistence o f  enteroviruses 
is unlikely to play a role in the developm ent o fC F S .
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